Novartis AG is 175.8x more valuable than Nuvation Bio Inc. by market capitalization ($283.13 B vs $1.61 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NUVB | NVS |
|---|---|---|
| Market cap | $1.61 B | $283.13 B |
| US-listed rank | #2262 | #47 |
| Revenue (latest FY) | $62.90M | - |
| Net income (latest FY) | -$204.63M | - |
| Net margin | -325.3% | - |
| SEC filings | 379 | 947 |
Novartis AG is 175.8x more valuable than Nuvation Bio Inc. by market capitalization ($283.13 B vs $1.61 B).
Full pages: Nuvation Bio Inc. and Novartis AG, or browse the full rankings.